secwatch.observer — SEC 8-K summary
======================================

Issuer:     SURGALIGN HOLDINGS, INC. (—)
CIK:        0001760173
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0001193125-22-280763
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Surgalign approves restructuring; expects $30-35M cash savings, $5.5-7M in costs
--------------------------------------------------------------------------------

- Board approved restructuring including workforce reductions and brand rationalization; estimated cash savings of $30-35M vs 2022.
- Restructuring costs estimated at $5.5-7.0M ($3.0-3.5M severance, $2.5-3.5M other exit costs) in Q4 2022 and Q1 2023.
- Exploration of further restructuring including potential sale or exit of certain domestic and international business aspects.
- Company also pursuing additional capital fundraising to supplement cash for operations and restructuring.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760173/000119312522280763/0001193125-22-280763-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760173/000119312522280763/d375805d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-280763

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer